Moderna says trial data shows its vaccine is safe and effective in children aged 6-11: Health officials say shot will be available to young kids in coming weeks Moderna said on Monday that its vaccine is safe and effective in children aged five to 11 Dosages for the youth will be the same half-sized doses
The EU’s medicines watchdog said on Friday that the bloc was likely to get 40 million more Moderna vaccine doses by October, after an output boost at two new US sites. The European Medicines Agency (EMA) in June gave the green light for the US sites in Massachusetts and New Hampshire to produce ingredients needed
Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration(Reuters) – Moderna Inc will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, S&P Dow Jones Indices said in a statement on Thursday. Moderna shares rose 6%
While researchers still have much to learn about the long-term effects of the COVID-19 vaccines, a new study offers potentially good news for those who’ve been vaccinated with the Pfizer and Moderna’s versions. The study, published in the journal Nature, suggests that these two vaccines produce persistent immunity, meaning those who’ve received them could be protected for years —
The Pfizer and Moderna COVID vaccines pose no threat to male fertility, a finding experts hope will prompt more men to get vaccinated. Researchers noted that the original clinical trials of the two mRNA vaccines didn’t assess how they might affect fertility. “Vaccine hesitancy is a barrier to ending the COVID-19 pandemic, and we believe
The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York City, two new studies show. The B.1.526 variant was first detected in November and accounted for nearly half of cases diagnosed in the city as of April 13. City officials have said the variant
Moderna says a third booster shot for its two-dose COVID-19 vaccine will be available in the United States by the fall. The announcement was made by company CEO Stéphane Bancel, CBS News reported. Studies show that the Moderna vaccine is more than 90 percent effective six months after the second dose, but it is unclear
Moderna confirms it is on track to deliver 100 million vaccine doses to America by March and 200 million by June as Biden promises that anyone who wants a shot will have it in spring Moderna Inc says it is on track to deliver 100 million coronavirus vaccine doses by March and 200 million in June
Moderna CEO says ‘we are going to have to live with coronavirus forever’ – but believes the firm’s vaccine is protective against the new variants from the UK, South Africa and Brazil Moderna CEO Stéphane Bancel spoke at a panel discussion at the JPMorgan Healthcare Conference on Wednesday He said the coronavirus is not going
American experts were set to discuss Thursday if Moderna’s COVID-19 vaccine should be authorized, as European nations vowed to get their coronavirus inoculation campaigns rolling before the end of the year. Surges in infections have prompted tighter restrictions in several European countries, while the United States—the worst-hit nation in the world—set a double record, with
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok